Black Hellebore (Helleborus niger L.): A Comprehensive Reference
1. Identity and Botanical Description
Taxonomic and Nomenclatural Identity
The botanical name is Helleborus niger L., for which "Black Hellebore" is the primary common synonym. It is a winter-blooming evergreen perennial belonging to the family Ranunculaceae. Additional common names include Christmas rose and Easter rose. The genus name derives from the Greek words helein, meaning "injures," and bora, meaning "food," referring to the plant's toxic properties when eaten. The specific epithet niger comes from the Latin word for "black," referring to the color of the roots.
In the early days of medicine, two kinds of hellebore were recognized: black hellebore, which included various species of Helleborus, and white hellebore — now known as Veratrum album, or "false hellebore" — which belongs to a different plant family, the Melanthiaceae. This distinction is pharmacologically important because the two genera are entirely unrelated botanically and toxicologically, and should not be confused.
Botanical Characteristics
It is a small perennial herb about 30 cm in height. The plant is native to Central and Southern Europe, not reaching Britain or North Germany, but extending eastward to South Poland and westward to Dauphiny and Provence. Its main distribution area today is the forested region of the eastern limestone Alps, where H. niger grows up to an altitude of 1,800 m, mostly on stony, bushy slopes with calcareous subsoil. The plant typically grows 8–15 inches tall and features large, cup-shaped, rose-like white flowers (up to 3 inches in diameter) with conspicuously contrasting yellow stamens; each flower has five large, showy petal-like sepals. It is an acaulescent species (without stems) that produces only basal leaves, each being palmate, deeply lobed, somewhat waxy, and dark green with 7–9 leaflets.
Medicinal Plant Part and Macroscopic Appearance
The plant's dried roots and rhizomes are used in diverse ailments in traditional and folklore remedies. Macroscopically, the roots are brownish-black in colour, cylindrical in shape, with a feeble odour, a slightly acrid taste, and irregularly branched. Microscopically, the root shows the presence of epidermis, air-chambers, fissure periderm, periderm, inner cortex, pith, phloem, xylem, vessels, and xylem vessels.
Confusable Species and Nomenclatural Complications
Research in the 1970s showed that the roots of H. niger do not contain the cardiotoxic compounds helleborin, hellebrin, and helleborein that are responsible for the lethal reputation of black hellebore; earlier studies may have used a commercial preparation containing a mixture of material from other species such as Helleborus viridis, the green hellebore. The supplement of the 6th edition of the German Pharmacopoeia describes that the drug Rhizoma Hellebori may originate from both H. niger L. and H. viridis L., and a clear pharmacognostic identification of Rhizoma (Radix) Hellebori nigri excluding other Helleborus species is noted to be difficult.
Common Forms and Preparations
Historically, the drug was recognized as possessing drastic purgative, emmenagogue, and anthelmintic properties; it was formerly used in dropsy and amenorrhoea, and administered as a tincture. In more recent and contemporary contexts, the following preparation forms are documented:
- Compound wine of hellebore (Vinum Hellebori Compositum) was a recognized historical preparation.
- Aqueous fermented extracts (designated HNE in research studies) have been the subject of preclinical investigation.
- Injectable aqueous plant extracts registered under German drug law are manufactured and diluted according to the German Homeopathic Pharmacopoeia.
- In homeopathy, D2 to D6 dilutions are common; the drug is also used in snuff powder form (at 10% average content) and as oral preparations.
- In accordance with the German Homeopathic Pharmacopeia, mother tinctures are also potentized to a dilution level of 12x, sterilized, and filled into ampoules without additional additives, for subcutaneous injection.
2. Traditional and Historical Use
Ancient Greece and Rome
The Christmas rose was known even in ancient times and used for medicinal purposes; Hippocrates administered Helleborus as a laxative and diuretic, and it was also considered a remedy against mental illness. Black hellebore was used by the ancients to treat insanity, melancholy, gout, and epilepsy. Pedanius Dioscorides documented hellebore in his foundational work De Materia Medica, written between 50 and 70 AD. This text became one of the cornerstones of Roman and later Christian and Islamic medicine, copied and used for almost two millennia.
Medieval Europe
In the Middle Ages, the Christmas rose was used as an ingredient in witches' ointments and considered an elixir for eternal youth. In the Middle Ages it was also used in treating madness, seizures, and "melancholy" due to its powerful effects on the nervous system. The English herbalist Nicholas Culpeper described preparations including a Syrupus Rosaccus Solutivus cum Helleboro (Syrup of Roses Solutive with Hellebore) for the purging of melancholy. Black hellebore (Helleborus niger) gets its name despite having white flowers; Culpeper noted that "the seeds are in colour black," and the dark roots were the primary name-giver.
Traditional Preparations Across Systems of Medicine
Traditionally, the H. niger root was used as a hydragogue cathartic and anthelmintic, and in epilepsy, dropsy, hypochondriasis, mania, melancholia, chronic skin affections, and worms; powdered roots were given in dyspepsia and as a purgative. The plant is used in Ayurvedic and Unani systems as well as in other herbal medicine systems. Helleborus species are used as phytopreparations with immunostimulatory properties in Romanian traditional medicine and were reported to possess anti-inflammatory activities in rheumatoid arthritis and varicella zoster infections.
Homeopathic Tradition
In homeopathy, its uses were refined by Samuel Hahnemann and further documented by early homeopaths such as William Boericke, who observed its impact on sensorial depression, low vitality, and fluid retention. In homeopathy, H. niger is still commonly used for meningitis, encephalitis, nephritis, epilepsy, heart failure, occipital pain, and dementia praecox. In Germany, Helleborus niger is used in homeopathy in cases of meningitis, convulsions, hydrocephalus, dropsy, and cachexia due to tumors, and as an adjuvant in tumor therapy via subcutaneous injections in anthroposophical medicine.
Anthroposophic Medicine
Even to this date, extracts of the rhizome and other subterranean parts of this plant are widely used in traditional medicine for a diverse range of symptoms and diseases; H. niger extracts are also applied in anthroposophic medicine, and clinical uses include the concomitant treatment of oncological diseases. In anthroposophic medicine, H. niger is used as an adjuvant drug in the treatment of brain tumors, leukemia, lymphoma, and prostate cancer.
Renaissance and Early Modern Medicine
Paracelsus, a Swiss physician during the medical renaissance, acknowledged the healing properties of Helleborus niger, and integrative medicine practitioners have been using it since the beginning of the 1900s. Paracelsus strongly regarded the leaf as a strong prophylactic against dementia, especially in "corpulent and phlegmatic" constitutions, as well as post-stroke and in excretion processes of the kidney.
3. Key Constituents and Active Compounds
Overview of Compound Classes
With respect to pharmacologically active ingredients, four compound classes are particularly relevant: steroidal saponins, ranunculin derivatives (including protoanemonin), beta-ecdysone, and flavonoids. Through reviewing recent articles, it was found that 226 compounds have been isolated and identified from the genus Helleborus; these compounds include steroids, flavonoids, phenylpropanoids, lignans, anthraquinones, phenolics, and others, with steroids being the main chemical constituents.
Bufadienolides: Hellebrin and Hellebrigenin
The main active ingredient of H. niger rhizomes is the bufadienolide hellebrin — a steroidal cardiac diglycoside with utility for heart failure treatment; hellebrin and its aglycon hellebrigenin are patented as lead compounds to treat cancer. Bufadienolides are chemically and biologically related to cardenolides and differ from them by the presence of a δ-lactone instead of a γ-lactone ring at C-atom 17 of the steroidal ring system; they have been found in two plant families — the Ranunculaceae (Helleborus species) and the Asparagaceae — as well as in the skin glands of toads (Bufonidae).
Hellebrin is a bufadienolide with similar cardiac activity but less toxicity than cardiac glycosides found in Digitalis and Strophanthus plants; its degradation products also strengthen heart contractions but are more toxic than the parent molecule; the aglycon hellebrigenin has the lowest lethal dose along with stronger cardiac activity; hellebrin and its derivatives are considered responsible for severe or lethal Christmas rose poisonings because their interference with the ion channels of the heart can lead to various arrhythmias.
The roots and rhizomes contain hellebrin, desgluco-hellebrin, hellebrigenin, bufatetraenolide, beta-ecdysterone, and 5-beta-hydroxyecdysterone.
Ranunculin, Protoanemonin, and Anemonin
The leaves, stems, and flowers of Helleborus niger contain ranunculin and ranuncoside — glycosides whose breakdown yields the toxin protoanemonin when plant cells are damaged. A key ingredient of H. niger is protoanemonin, which is responsible for its burning hot taste and vesicant effect; protoanemonin possesses antibacterial, antifungal, cytotoxic, and antimutagenic activity; anemonin, the dimer of protoanemonin, has antimicrobial, anti-inflammatory, and antimalarial activity, whereas (−)-ranunculin, a protoanemonin glycoside, possesses cytotoxicity and antimutagenic activity.
Ecdysteroids
Recent analytical investigations on Helleborus niger verified the presence of the steroid hormone β-ecdysone and the steroid saponin macranthosid I, and confirmed earlier results that neither the heart-glycoside helleborin nor other classical steroidal glycosides were detected in authentic H. niger root. Additional bufadienolides as well as ecdysteroids were recently isolated from H. niger whole plants and showed potent cytotoxicity on human cancer cell lines.
Steroidal Saponins and Flavonoids
Various saponins have been determined by mass spectrometry, of which four compounds isolated from the rhizome are awaiting pharmacological assessment. The plants also contain aconitic acid and kaempferol glycosides. The aerial parts of H. niger comprise a substantial number of constituents; extracts from leaves and stems investigated by liquid chromatography/tandem mass spectrometry were found to contain acylated and non-acylated quercetin and kaempferol oligoglycosides, protoanemonin, and its derivatives.
Historical Constituents vs. Modern Findings: A Critical Note
The root and root-leaves of various species of Helleborus contain two glucosides: helleborein, which is a cardiac poison with drastic properties, and helleborin, a narcotic poison; also fatty oil, acrid resins, and no tannin. However, this classical description applies broadly to the genus, not specifically to H. niger. Helleborus viridis is stated to yield a more active helleborein than H. niger; the same plant yields the largest amount of helleborin (0.04 percent). The 1970s pharmacological re-evaluation established that these potent cardiac glycosides may have been attributed to H. niger erroneously due to adulteration with other species in commercial preparations.
4. Established and Proposed Mechanisms of Action
Cardiac Glycoside-Like Mechanism (Bufadienolides)
Black hellebore contains crystalline cardiac glycoside-like compounds (hellebrin); these substances have an action similar to that of the glycosides found in common Foxglove (Digitalis purpurea). Hellebrin and hellebrigenin have the capacity to bind to the potassium-sodium pump ATPase of cancer cells (alpha subunits) and to suppress cancer cell viability. Prassas et al. (2011) proposed that cardiac glycosides have the ability to induce selectively apoptotic cell death in cancer cells compared with normal cells by altering the expression of potassium-sodium pump subunits.
Anti-Angiogenic and Anti-Proliferative Effects
A broad pharmacological spectrum is ascribed to the Christmas rose because of its multitude of compounds: anti-bacterial, anti-inflammatory, cholesterol- and blood glucose-lowering, neuroprotective, hepatoprotective, and immune-modulating effects. Preclinical investigations have elaborated anti-angiogenic characteristics on human umbilical vein endothelial cells (HUVEC) as well as anti-proliferative and non-migratory properties of HNE on cancer cells.
Apoptosis Induction
Due to the composition of bufadienolide and ecdysteroid, H. niger extract has demonstrated antitumor capacity by inducing apoptosis. An undescribed bufadienolide rhamnoside isolated from H. niger induced apoptosis in SBC-3 (small-cell lung cancer) cells.
Immunomodulatory Mechanisms
To stimulate the immune system non-specifically in the related species H. purpurascens, roots were transcutaneously implanted; in animals treated with this method, an increase of leukocytes, neutrophils, and phagocytosis was observed. In vitro application of an aqueous extract from Helleborus niger resulted in a slight induction of sister chromatid exchanges (SCE) in cultured peripheral blood mononuclear cells (PBMC) from healthy individuals, an effect associated with a slight increase of [3H]thymidine uptake in the DNA of isolated lymphocytes. This finding raised a DNA-destabilizing concern discussed further in the safety section.
Toxicity-Related Mechanisms
Two compound groups — the ranunculin derivatives including protoanemonin, and the steroidal saponins — are associated with toxicity, specifically genotoxicity and disintegration of membrane structures. When locally applied, black hellebore causes irritation of mucous membranes and of the conjunctiva, inducing redness, swelling, and increased secretion; a considerable internal quantity causes loss of appetite, nausea, vomiting, and pain and inflammation of the stomach and bowels.
5. Scientific Evidence by Area of Use
5.1 Oncology and Antitumor Activity
Evidence level: Preclinical only (in vitro/cell line studies). No human clinical trials published.
Helleborus therapy is not yet supported by clinical trials in humans; the research that exists is promising but early-stage, based primarily on cell line and laboratory studies.
In the most directly relevant study, in anthroposophic medicine H. niger is used as an adjuvant drug in brain tumors, leukemia, lymphoma, and prostate cancer; researchers investigated the cytotoxic effects of four different standardized aqueous H. niger extracts — a whole plant extract, a root extract, a leaf extract, and one containing only the blossom — on various cancer cell lines.
In a phytochemical study, compounds isolated from whole plants of H. niger were evaluated for cytotoxic activity against HL-60 human leukemia cells, A549 human lung adenocarcinoma cells, SBC-3 human small-cell lung cancer cells, and TIG-3 human normal diploid lung cells; the compounds showed cytotoxic activity against HL-60, A549, and SBC-3 cells with IC50 values ranging from 0.0016 to 6.1 μM.
A 2019 preclinical study published in BMC Complementary Medicine and Therapies evaluated the safe use of HNE via Ames and hemolytic tests and conducted two angiogenesis assays in 2D and 3D design on HUVEC cells, as well as using a panel of tumor cell lines in 2D and 3D proliferation assays, migration assays, and invasion assays.
A 2014 study published in ScienceDirect examined differential cytotoxicity: in Romanian folk medicine H. niger is used for rheumatoid arthritis or viral infections and in complementary therapy, especially anthroposophic medicine, as an adjuvant for malignant diseases; the study investigated differential cytotoxic effects on human tumor and healthy immune system cells in vitro, quantified protoanemonin and saponins in five individual batches, and monitored impact on proliferation capacity (MTT assay), apoptosis, and necrosis induction, as well as NK cell function (degranulation-CD107a assay and IFN-gamma secretion).
Overall, recent preclinical evaluations showed pharmacologic potential of the plant extract for cancer treatment. However, all available oncology evidence is from cell lines and in vitro systems; no human or animal in vivo trials are published establishing therapeutic benefit in cancer patients.
5.2 Neurology and Dementia
Evidence level: One retrospective cohort study (highly preliminary); prior use is primarily traditional and homeopathic.
Helleborus niger, containing multiple bioactive compounds such as ecdysteroids and bufadienolide, is used clinically for its immunomodulatory, anti-inflammatory, analgesic, and antioxidant properties; in a German hospital specializing in geriatric patients, an association between the subcutaneous application of Helleborus niger 12x and changes in dementia was observed.
A retrospective cohort study published in Frontiers in Public Health (2026) examined this observation formally: it was a retrospective study on the effect of subcutaneous application of Helleborus niger 12x for an average of 3 weeks in patients with dementia. Eligible patients were aged ≥ 60 years and treated at the Humboldt Clinic in Bad Steben, Bavaria, Germany, with two treatment regimens: standard care with conventional medication alone (control group) versus standard care with conventional medication plus Helleborus niger 12x preparations (Helleborus group). The study design is retrospective and observational, meaning confounding cannot be excluded. The highly diluted (12x) homeopathic preparation contains vanishingly small amounts of active constituents; the pharmacological relevance of such dilutions is scientifically contentious. No controlled prospective trial exists.
5.3 Immunomodulation
Evidence level: In vitro and traditional/folk use. No human clinical trials.
Extracts of Helleborus species are used as phytopreparations with immunostimulatory properties in Romanian traditional medicine; in Germany, Helleborus niger is used in homeopathy and as an adjuvant therapy in the treatment of tumor patients in anthroposophical medicine. In vitro investigations have shown stimulation of lymphocyte DNA synthesis and SCE induction, but these findings also raise genotoxicity concerns (see Safety section). Pharmacological studies show Helleborus has immunomodulatory properties among other activities.
5.4 Anti-Inflammatory and Analgesic Applications
Evidence level: Traditional/folk use; in vitro data; no human clinical trials for H. niger specifically.
In folk medicine, the genus is commonly used as an anti-inflammatory and analgesic medicine for rheumatoid arthritis and bruises; 226 compounds have been isolated and identified from the genus Helleborus. Anemonin, the dimer of protoanemonin, has antimicrobial, anti-inflammatory, and antimalarial activity, whereas (−)-ranunculin, a protoanemonin glycoside, possesses cytotoxicity and antimutagenic activity. The available evidence is largely restricted to the genus level, in vitro, or derived from related species such as H. purpurascens and H. orientalis.
5.5 Cardiovascular Uses
Evidence level: Historical and pharmacological characterization only; no modern clinical trials.
The main active ingredient of H. niger rhizomes, hellebrin, is a steroidal cardiac diglycoside with utility for heart failure treatment described in the pharmacological literature. Today, only the roots of Helleborus niger are used in certain human medicines to treat cardiovascular problems. However, the drug is occasionally employed in veterinary practice but is largely obsolete in mainstream medicine. No modern randomized controlled trials evaluating H. niger preparations for cardiovascular endpoints in humans have been published.
5.6 Antimicrobial Activity
Evidence level: In vitro studies with protoanemonin as an isolated constituent; no human clinical trials.
The concentration levels and stability of protoanemonin, a characteristic constituent of Ranunculaceae species with antimicrobial and fungicidal properties, were studied in plant extracts prepared from Helleborus niger L. Protoanemonin possesses antibacterial, antifungal, cytotoxic, and antimutagenic activity, and its isolation, synthesis, and preparation as a therapeutically valuable medicinal product are well elaborated in the literature. These findings are from isolated compound studies and have not been translated into clinical antimicrobial applications.
5.7 Metabolic and Other Effects
Evidence level: Preclinical and in vitro data; no human clinical trials.
A broad pharmacological spectrum is ascribed to the Christmas rose: anti-bacterial, anti-inflammatory, cholesterol- and blood glucose-lowering, neuroprotective, hepatoprotective, and immune-modulating effects. Degradation of protoanemonin results in anemonin, a compound with sedative, anti-inflammatory, and antimicrobial properties; research also indicates that anemonin can significantly reduce blood glucose levels in patients with diabetic nephropathy. These findings are derived from preclinical models and require human validation before any therapeutic inference can be drawn.
6. Body Systems and Health Areas of Association
Based on the documented traditional, homeopathic, and preclinical scientific literature, the following body systems are consistently associated with H. niger:
- Central Nervous System: Historically used for insanity, melancholy, epilepsy, and stupor; in homeopathy for dementia, meningitis, and encephalitis; modern investigation of neuroprotective potential.
- Cardiovascular System: Contains hellebrin, a bufadienolide with cardiac glycoside-like activity; historical use in dropsy (edema); potential use in heart failure based on pharmacological characterization.
- Immune System: Traditional immunostimulatory use in Romanian folk medicine; in vitro evidence for lymphocyte modulation and NK cell function effects.
- Oncology (adjuvant): Used as a complementary drug in the treatment of many types of cancers and associated symptoms, as well as for chronic inflammatory diseases, edema, and brain and kidney diseases.
- Renal System: H. niger is related to the renal system because of its diuretic effect and its ability to support elimination of edema through kidney activation.
- Gastrointestinal System: Historical use as a cathartic (purgative), anthelmintic, and treatment for dyspepsia.
- Musculoskeletal System: In folk medicine it is commonly used as an anti-inflammatory and analgesic medicine for rheumatoid arthritis and bruises.
7. Dosage Forms and Reported Dosages
According to the supplement of the 6th edition of the German Pharmacopoeia, the largest single dose prescribed is 0.2 g, the largest daily dose is 1.0 g, and the average single dose as ingestion is 0.05 g; the average content as snuff powder is 10%. In homeopathy, D2 to D6 dilutions are common for oral preparations. In accordance with the German Homeopathic Pharmacopeia, injectable preparations are potentized to a dilution level of 12x, sterilized, and filled into ampoules.
In the preclinical oncology research context, whole plants of H. niger (4.5 kg) were subjected to methanol extraction; the resulting methanol extract showed cytotoxicity against HL-60, A549, and SBC-3 cells with IC50 values of 2.6, 1.8, and 1.9 μg/mL, respectively. These are in vitro concentrations only and do not translate to human dosing recommendations.
In the retrospective dementia study, the intervention involved subcutaneous application of Helleborus niger 12x for an average of 3 weeks.
Historical eclectic pharmacy records describe: a dose of one-half ounce to two ounces for Compound Wine of Hellebore, and a dose of one-tenth to three minims for the Specific Medicine preparation. These are historical references and are not recommendations for current use.
8. Safety Considerations and Toxicology
General Plant Toxicity
All parts of the Christmas rose plant are considered toxic upon consumption or physical contact with sap from damaged plant tissues; its organs contain varying levels of different glycosides, which are common plant defense mechanisms against herbivores and microorganisms.
Protoanemonin-Mediated Toxicity
The leaves, stems, and flowers of H. niger contain ranunculin and ranuncoside, glycosides whose breakdown yields the toxin protoanemonin when plant cells are damaged; protoanemonin has an unpleasant taste and can cause irritation of the skin, mucosa, and eyes upon contact; if large amounts are ingested, the toxin can cause itching and blistering of the mouth and throat, as well as gastroenteritis and hematemesis in both humans and animals. The high amounts of ranunculin or protoanemonin in the leaves, stems, and flowers are responsible for dermatitis (following exposure to bruised root material, leaves, stems, and flowers), eye irritation (powdered root), and gastrointestinal irritations (following ingestion): salivation, mouth and throat tingling, abdominal pain, vomiting, purging, and diarrhea.
Bufadienolide-Mediated Cardiac Toxicity
Historically reported toxicity from black hellebore includes tinnitus, vertigo, stupor, thirst, a feeling of suffocation, swelling of the tongue and throat, emesis and catharsis, bradycardia (slowing of the pulse), and finally collapse and death from cardiac arrest. As noted, some of these severe effects may have resulted from adulteration with other species. Some authors claim that the cardiac symptoms reported are likely caused by other Helleborus species rather than by H. niger itself, and mixing of root preparations with H. viridis is specifically suggested as a cause of confusion.
Steroidal Saponin-Related Toxicity and Genotoxicity Concern
Ranunculin derivatives including protoanemonin and the steroidal saponins are associated with toxicity involving genotoxicity and disintegration of membrane structures. Considering the proposed immunomodulatory and anti-inflammatory properties and the treatment of patients with cancer and rheumatoid arthritis with this drug, a DNA-destabilizing risk has been identified as requiring definition; to assess possible mutagenic and carcinogenic effects, researchers determined the sister chromatid exchange (SCE) frequency of cultured peripheral blood mononuclear cells (PBMC) from healthy individuals after the addition of 'Helleborus niger D3 aquos' in vitro. The SCE induction observed in that in vitro study constitutes a warning signal that has not been definitively resolved in clinical contexts.
Species Identification and Adulteration Risk
Until the 1970s, even scientists used a commercial preparation (Hellebori radix) containing a mixture of material from different species of hellebore, so some homeopathic pharmacies may also have used this mixed preparation. Reliable pharmacognostic identification of authentic H. niger root, as distinct from H. viridis or other congeners, remains a practical challenge confirmed by the German Pharmacopoeia's inclusion of both species under the same drug name.
Degradation of Protoanemonin During Processing
Protoanemonin levels quantified by HPLC-DAD analysis were 0.0345 and 0.0662 mg/g in two freshly prepared Helleborus (whole, flowering plant) extracts. Fermentative processing and aqueous extraction methods used in anthroposophic and homeopathic preparations are intended to reduce protoanemonin content; the stability and residual levels of this constituent in finished preparations are an active area of analytical research.
Interactions
No formally published human pharmacokinetic drug-interaction studies for H. niger preparations have been identified in the peer-reviewed literature. However, several theoretical interactions are supported by the plant's known pharmacology:
- Cardiac glycoside drugs (e.g., digoxin): Because hellebrin and hellebrigenin act on Na+/K+-ATPase in a manner analogous to cardiac glycosides, additive or synergistic effects on cardiac contractility and ion channel function are mechanistically plausible.
- Diuretics: The documented diuretic properties of H. niger could theoretically potentiate the effects of pharmaceutical diuretics and increase the risk of electrolyte imbalance, particularly hypokalemia, which would compound cardiac glycoside toxicity.
- Immunosuppressants / immunomodulatory drugs: Given the in vitro immunostimulatory effects documented in Romanian folk medicine studies and the SCE-inducing activity in PBMC culture, additive or opposing effects with immunosuppressant medications are theoretically possible.
9. Regulatory and Pharmacopoeial Status
The supplement of the 6th edition of the German Pharmacopoeia describes the drug Rhizoma Hellebori as originating from H. niger L. and H. viridis L.; the largest single dose prescribed is 0.2 g, the largest daily dose is 1.0 g, and the average single dose as ingestion is 0.05 g. Injectable plant extracts for anthroposophic and homeopathic use are registered products under German drug law, manufactured and diluted according to the German Homeopathic Pharmacopoeia. In France, Helleborus niger is listed in the French and European Pharmacopoeia and is registered as a homeopathic substance. H. niger does not hold an approved therapeutic indication from the European Medicines Agency (EMA) or regulatory monograph equivalent to those issued for well-established herbal medicines, and it is not included in the NIH Office of Dietary Supplements or NCCIH fact sheets as a reviewed supplement. Its contemporary medicinal use is confined primarily to homeopathic and anthroposophic regulated frameworks within European jurisdictions.
References
Go back